← Evidence map

ArticleJournal of neuro-oncology2024

Enhancing Temozolomide (TMZ) chemosensitivity using CRISPR-dCas9-mediated downregulation of O

Yasamin Yousefi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38762829